日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Molecular Signature of the Ubiquitin-Proteasome System for Forecasting Prognosis in Thyroid Carcinoma Patients.

泛素-蛋白酶体系统的分子特征可用于预测甲状腺癌患者的预后

Zeng Hong, Geng Xitong, Wan Hao, Qu Xiaoyu, Tang Shengwei, Zhang Ruiyu, Zhou Minqin, Yu Zichuan, Pan Jingying, Zheng Hao, Zhu Yanting, Huang Shuhan, Huang Da

LAMP3 is a potent uterine corpus endometrial carcinoma prognostic biomarker associated with immune behavior

LAMP3是一种与免疫行为相关的强效子宫内膜癌预后生物标志物。

Fu, Bidong; Zhou, Minqin; Geng, Xitong; Jiang, Yike; Zeng, Hong; Zhou, Xuanrui; Yu, Zichuan; Pan, Jingying; Zhu, Yanting; Zheng, Hao; Huang, Shuhan; Gong, Yiyang; Huang, Da; Zhong, Yanying

Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification

基于综合计算生物学和实验验证,鉴定出胶质瘤的可靠生物标志物LAPTM4A

Ding, Yongqi; Jiang, Yike; Zeng, Hong; Zhou, Minqin; Zhou, Xuanrui; Yu, Zichuan; Pan, Jingying; Geng, Xitong; Zhu, Yanting; Zheng, Hao; Huang, Shuhan; Gong, Yiyang; Huang, Huabin; Xiong, Chengfeng; Huang, Da

An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer

与上皮间质转化(EMT)相关的免疫生物标志物可作为膀胱癌预后和药物反应的预测因子。

Jiang, Yike; Yu, Zichuan; Zheng, Hao; Zhou, Xuanrui; Zhou, Minqin; Geng, Xitong; Zhu, Yanting; Huang, Shuhan; Gong, Yiyang; Guo, Liangyun

Correction for: Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma

更正:对肝细胞癌中 ZSCAN20 的预后价值、与细胞周期、免疫浸润和 m6A 修饰的关系进行综合分析

Jiayu, Fang; Jiang, Yike; Zhou, Xuanrui; Zhou, Minqin; Pan, Jingying; Ke, Yun; Zhen, Jing; Huang, Da; Jiang, Weifan

Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma

ARHGAP39作为肝细胞癌独立预后生物标志物的生物学功能分析

Ding, Yongqi; Gong, Yiyang; Zeng, Hong; Zhou, Xuanrui; Yu, Zichuan; Pan, Jingying; Zhou, Minqin; Liu, Shiwen; Lai, Wei

Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity

研究发现RP2是胶质瘤的预后生物标志物,主要通过调节肿瘤免疫促进胶质瘤的发生发展。

Gong, Yiyang; Ke, Yun; Yu, Zichuan; Pan, Jingying; Zhou, Xuanrui; Jiang, Yike; Zhou, Minqin; Zeng, Hong; Geng, Xitong; Hu, Guowen

Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma

综合分析表明,TSEN54 是一种可靠的预后生物标志物,也是肝细胞癌治疗中一个有前景的免疫相关靶点。

Fu, Bidong; Zhou, Minqin; Song, Gelin; Zeng, Hong; Gong, Yiyang; Jiang, Yike; Ke, Yun; Huang, Da; Peng, Hong; Li, Qing

ZNF320 is a hypomethylated prognostic biomarker involved in immune infiltration of hepatocellular carcinoma and associated with cell cycle

ZNF320 是一种低甲基化的预后生物标志物,参与肝细胞癌的免疫浸润,并与细胞周期相关。

Zhen, Jing; Ke, Yun; Pan, Jingying; Zhou, Minqin; Zeng, Hong; Song, Gelin; Yu, Zichuan; Fu, Bidong; Liu, Yue; Huang, Da; Wu, Honghu

Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma

对肝细胞癌中ZSCAN20的预后价值、与细胞周期、免疫浸润和m6A修饰的关系进行综合分析

Jiayu, Fang; Jiang, Yike; Zhou, Xuanrui; Zhou, Minqin; Pan, Jingying; Ke, Yun; Zhen, Jing; Huang, Da; Jiang, Weifan